Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9BWG6: Variant p.Pro51Gln

Sodium channel modifier 1
Gene: SCNM1
Feedback?
Variant information Variant position: help 51 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Proline (P) to Glutamine (Q) at position 51 (P51Q, p.Pro51Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (P) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In OFD19; the genetic variation producing this missense variant predominantly affects splicing and the resulting mRNA is predicted to undergo nonsense-mediated mRNA decay. Any additional useful information about the variant.


Sequence information Variant position: help 51 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 230 The length of the canonical sequence.
Location on the sequence: help EDEALMLRDGRFACAICPHR P VLDTLAMLTAHRAGKKHLSS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         EDEALMLRDGRFACAICPHRPVLDTLAMLTAHRAGKKHLSS

Mouse                         EDEALMLRDGRFACAICPHRPVLDTLAMLTAHRAGKKHLSS

Bovine                        EDEALMLRDGRFACAICPHRPVLDTLAMLTAHRAGKKHLSS

Xenopus laevis                EDEALLLKNGSYACTVCHHRPVFNTIDMLSVHRTGKKHLGG

Zebrafish                     DDEATLMKNGRYSCLVCSHRPVFDTVDMLVVHRKGKRHLEG

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 230 Sodium channel modifier 1
Zinc finger 42 – 74 Matrin-type
Cross 67 – 67 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)



Literature citations
Mutations in SCNM1 cause orofaciodigital syndrome due to minor intron splicing defects affecting primary cilia.
Iturrate A.; Rivera-Barahona A.; Flores C.L.; Otaify G.A.; Elhossini R.; Perez-Sanz M.L.; Nevado J.; Tenorio-Castano J.; Trivino J.C.; Garcia-Gonzalo F.R.; Piceci-Sparascio F.; De Luca A.; Martinez L.; Kalayci T.; Lapunzina P.; Altunoglu U.; Aglan M.; Abdalla E.; Ruiz-Perez V.L.;
Am. J. Hum. Genet. 109:1828-1849(2022)
Cited for: INVOLVEMENT IN OFD19; VARIANT OFD19 GLN-51; CHARACTERIZATION OF VARIANT OFD19 GLN-51; FUNCTION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.